Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
PC 360
Article
Trump executive order presents challenges for workers’ comp, auto insurers
Workers' Comp
Article
Accelerating Recovery and Return to Work: The Case for Case Management
In workers’ compensation, one of the most effective ways to reduce claim duration and associated costs is to get injured employees back to work—saf
Workers' Comp
Article
Turning Regulatory Obstacles into Strategy Advantages Using Informed Decision-Making in Workers’ Comp & Auto Casualty
Following our examination of President Trump's health care executive order and its implications for workers' compensation and auto payers in
WorkcompWire
Article
Ripple Effect: Potential Impacts of Tariffs and Proposed Medicaid Cuts on Workers’ Comp
Workers' Comp
Article
Strengthening Return-to-Work Outcomes: A Guide to Vocational Case Management for Claims Professionals
When a workplace injury disrupts an employee’s ability to work, the path back to productivity can be complex.
Insurance Journal
Article
A True Alternative to Opioids for Workers’ Comp? Questions Remain
Enlyte’s Nikki Wilson weighs in on suzetrigine as a potential opioid alternative in workers’ comp.